Double Digit NASDAQ Stock Winners: MTP, APOP, SNPX
12:09 pm Friday, June 18th, 2021
Following are major stock gainers on Nasdaq in Thursday ‘s trading session:
Midatech Pharma plc (NASDAQ:MTP) was the active stock gainer on Thursday . The stock soared 44.64% to close $2.95 after the company announced a breakthrough in vitro data utilizing Q-Sphera technology and progress across multiple other programs. The technology showed potential to formulate proteins into long-acting injectable products.
Q-Sphera can encapsulate drugs in polymer-based bioresorbable microspheres, which may be injected to form depots in the body that release drugs over predictable, sustained periods from one week to several months.
Cellect Biotechnology Ltd. (NASDAQ:APOP) was another notable winner as the stock went up 27% to end the session at $4.15. The company announced that it has filed a registration statement, including a joint proxy statement/prospectus, with the Securities and Exchange Commission (SEC) in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals. Quoin is a specialty pharmaceutical company focused on rare and orphan diseases.
Synaptogenix, Inc. (NASDAQ:SNPX) surged 25% to $11.13. The company announced that it has executed securities purchase agreements to raise gross proceeds of approximately $12.5 million in a private placement financing of common stock and warrants (“Units”). The financing was led primarily by existing institutional shareholders.
Synaptogenix intends to use the net proceeds from the private placement to support the ongoing development of Bryostatin-1, which is currently in a Phase 2b National Institutes of Health (“NIH”) sponsored Alzheimer’s disease (“AD”) trial, as well as additional research and development for new indications.
